Clinical

Dataset Information

0

Pilot study of chemopreventive effect of pioglitazone for colorectal cancer using aberrant crypt foci as a biomarker


ABSTRACT: Interventions: Oral administration of pioglitazone in 15mg daily. No administration of newly drug. Primary outcome(s): Observation of ACF using magnifying endoscopy Study Design: Parallel Randomized

DISEASE(S): Subjects With Aberrant Crypt Foci (acf)

PROVIDER: 2616758 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2627745 | ecrin-mdr-crc
| 2619196 | ecrin-mdr-crc
| 2692577 | ecrin-mdr-crc
| 2625370 | ecrin-mdr-crc
| PRJNA703971 | ENA
| 2634032 | ecrin-mdr-crc
2018-01-23 | GSE95654 | GEO
| 2095836 | ecrin-mdr-crc
| 2625667 | ecrin-mdr-crc
2015-06-09 | E-ERAD-369 | biostudies-arrayexpress